Amsterdam
,
Netherlands
7 - 10 May 2025
European Association for the Study of the Liver Congress (EASL 2025)
Presentation schedule and materials
Wednesday, 07 May 2025
08:30
- 16:00
CEST
LBP-019
POSTER
Semaglutide-treated participants in the phase 3 ESSENCE trial (part 1) have greater concordance of non-invasive test improvements compared with placebo
Mary E. Rinella1; Manal F. Abdelmalek2; Elisabetta Bugianesi3; Anna M.G. Calí4; Laurent Castera5,6; Kristiane A. Engebretsen4; Jacob George7; Wah Kheong Chan8; Niels Krarup4; Michelle T. Long4; Philip Newsome9,10; Cláudia P. Oliveira11; Georgios Papatheodoridis12; Ahsan Shoeb4; Salvatore Petta13; Michael Roden14,15,16; Arun J. Sanyal17; Yusuf Yilmaz18; Vlad Ratziu19; on behalf of the ESSENCE Study Group
MATERIALS AVAILABLE
Thursday, 08 May 2025
12:45
- 13:45
CEST
Symposium
Updates on the essence of MASH
Elizabeth Powell
;
Philip Newsome
;
Faiez Zannad
;
Steven Kahn
MATERIALS AVAILABLE
Saturday, 10 May 2025
11:45
- 12:45
CEST
Symposium
Personalised management of MASH
Jörn M. Schattenberg
;
Alina M. Allen
;
Jean-Francois Dufour
MATERIALS AVAILABLE
Keywords